Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Metabolic Characterization of Supernatants Produced by Lactobacillus spp. With in vitro Anti-Legionella Activity.

Fuochi V, Coniglio MA, Laghi L, Rescifina A, Caruso M, Stivala A, Furneri PM.

Front Microbiol. 2019 Jun 26;10:1403. doi: 10.3389/fmicb.2019.01403. eCollection 2019.

2.

Lipid Nanoparticles And Active Natural Compounds: A Perfect Wedding For Pharmaceutical Applications.

Puglia C, Pignatello R, Fuochi V, Furneri PM, Lauro MR, Santonocito D, Cortesi R, Esposito E.

Curr Med Chem. 2019 Jun 14. doi: 10.2174/0929867326666190614123835. [Epub ahead of print]

PMID:
31203795
3.

Biological properties of Cakile maritima Scop. (Brassicaceae) extracts.

Fuochi V, Barbagallo I, Distefano A, Puglisi F, Palmeri R, Di Rosa M, Giallongo C, Longhitano L, Fontana P, Sferrazzo G, Tiralongo F, Raccuia SA, Ronsisvalle S, Li Volti G, Furneri PM, Tibullo D.

Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):2280-2292. doi: 10.26355/eurrev_201903_17277.

PMID:
30915777
Free Article
4.

Biological properties and production of bacteriocins-like-inhibitory substances by Lactobacillus sp. strains from human vagina.

Fuochi V, Cardile V, Petronio Petronio G, Furneri PM.

J Appl Microbiol. 2019 May;126(5):1541-1550. doi: 10.1111/jam.14164. Epub 2019 Feb 20.

PMID:
30499608
5.

Commentary: Inflammatory and Oxidative Responses Induced by Exposure to Commonly Used e-Cigarette Flavoring Chemicals and Flavored e-Liquids without Nicotine.

Caruso M, Li Volti G, Furneri PM, Fuochi V, Emma R, Polosa R.

Front Physiol. 2018 Sep 13;9:1240. doi: 10.3389/fphys.2018.01240. eCollection 2018. No abstract available.

6.

Electronic cigarette vapour enhances pneumococcal adherence to airway epithelial cells under abnormal conditions of exposure.

Caruso M, Emma R, Fuochi V, Furneri PM, Polosa R.

Eur Respir J. 2018 Sep 6;52(3). pii: 1800915. doi: 10.1183/13993003.00915-2018. Print 2018 Sep. No abstract available.

PMID:
30190260
7.

A Method for Efficient Loading of Ciprofloxacin Hydrochloride in Cationic Solid Lipid Nanoparticles: Formulation and Microbiological Evaluation.

Pignatello R, Leonardi A, Fuochi V, Petronio Petronio G, Greco AS, Furneri PM.

Nanomaterials (Basel). 2018 May 6;8(5). pii: E304. doi: 10.3390/nano8050304.

8.

Repurposing itraconazole to the benefit of skin cancer treatment: A combined azole-DDAB nanoencapsulation strategy.

Carbone C, Martins-Gomes C, Pepe V, Silva AM, Musumeci T, Puglisi G, Furneri PM, Souto EB.

Colloids Surf B Biointerfaces. 2018 Jul 1;167:337-344. doi: 10.1016/j.colsurfb.2018.04.031. Epub 2018 Apr 17.

PMID:
29684903
9.

Antioxidant and antimicrobial properties of Casteanea sativa Miller chestnut honey produced on Mount Etna (Sicily).

Ronsisvalle S, Lissandrello E, Fuochi V, Petronio Petronio G, Straquadanio C, Crascì L, Panico A, Milito M, Cova AM, Tempera G, Furneri PM.

Nat Prod Res. 2019 Mar;33(6):843-850. doi: 10.1080/14786419.2017.1413568. Epub 2017 Dec 13.

PMID:
29232982
10.

Lipid-based Nanosized Delivery Systems for Fluoroquinolones: a Review.

Furneri PM, Fuochi V, Pignatello R.

Curr Pharm Des. 2017 Nov 21. doi: 10.2174/1381612823666171122110103. [Epub ahead of print]

PMID:
29173152
11.

Antimicrobial and Anti-Proliferative Effects of Skin Mucus Derived from Dasyatis pastinaca (Linnaeus, 1758).

Fuochi V, Li Volti G, Camiolo G, Tiralongo F, Giallongo C, Distefano A, Petronio Petronio G, Barbagallo I, Viola M, Furneri PM, Di Rosa M, Avola R, Tibullo D.

Mar Drugs. 2017 Nov 1;15(11). pii: E342. doi: 10.3390/md15110342.

12.

Commentary: Lactobacilli Dominance and Vaginal pH: Why Is the Human Vaginal Microbiome Unique?

Fuochi V, Li Volti G, Furneri PM.

Front Microbiol. 2017 Sep 25;8:1815. doi: 10.3389/fmicb.2017.01815. eCollection 2017. No abstract available.

13.

Probiotic Properties of Lactobacillus fermentum Strains Isolated from Human Oral Samples and Description of their Antibacterial Activity.

Fuochi V, Volti GL, Furneri PM.

Curr Pharm Biotechnol. 2017;18(2):138-149. doi: 10.2174/1389201017666161229153530.

PMID:
28034294
14.
15.

Synthesis, characterization and in vitro evaluation of amphiphilic ion pairs of erythromycin and kanamycin antibiotics with liposaccharides.

Pignatello R, Simerska P, Leonardi A, Abdelrahim AS, Petronio GP, Fuochi V, Furneri PM, Ruozi B, Toth I.

Eur J Med Chem. 2016 Sep 14;120:329-37. doi: 10.1016/j.ejmech.2016.04.074. Epub 2016 May 6.

PMID:
27236014
16.

Key Roles of Human Polymorphonuclear Cells and Ciprofloxacin in Lactobacillus Species Infection Control.

Mandras N, Tullio V, Furneri PM, Roana J, Allizond V, Scalas D, Petronio Petronio G, Fuochi V, Banche G, Cuffini AM.

Antimicrob Agents Chemother. 2015 Dec 28;60(3):1638-41. doi: 10.1128/AAC.01637-15.

17.

Labeling quality and molecular characterization studies of products containing Lactobacillus spp. strains.

Blandino G, Fazio D, Petronio GP, Inturri R, Tempera G, Furneri PM.

Int J Immunopathol Pharmacol. 2016 Mar;29(1):121-8. doi: 10.1177/0394632015600534. Epub 2015 Dec 14.

18.

Evaluation of resistance to low pH and bile salts of human Lactobacillus spp. isolates.

Fuochi V, Petronio GP, Lissandrello E, Furneri PM.

Int J Immunopathol Pharmacol. 2015 Sep;28(3):426-33. doi: 10.1177/0394632015590948. Epub 2015 Jul 27.

PMID:
26216909
19.

Preparation and Microbiological Evaluation of Amphiphilic Kanamycin-Lipoamino Acid Ion-Pairs.

Pignatello R, Leonardi A, Petronio GP, Ruozi B, Puglisi G, Furneri PM.

Antibiotics (Basel). 2014 May 26;3(2):216-32. doi: 10.3390/antibiotics3020216.

20.

Anti-Adhesion Activity of A2-type Proanthocyanidins (a Cranberry Major Component) on Uropathogenic E. coli and P. mirabilis Strains.

Nicolosi D, Tempera G, Genovese C, Furneri PM.

Antibiotics (Basel). 2014 Apr 3;3(2):143-54. doi: 10.3390/antibiotics3020143.

21.

In vitro antimycoplasmal activity of Citrus bergamia essential oil and its major components.

Furneri PM, Mondello L, Mandalari G, Paolino D, Dugo P, Garozzo A, Bisignano G.

Eur J Med Chem. 2012 Jun;52:66-9. doi: 10.1016/j.ejmech.2012.03.005. Epub 2012 Mar 11.

PMID:
22465092
22.

Amphiphilic erythromycin-lipoamino acid ion pairs: characterization and in vitro microbiological evaluation.

Pignatello R, Mangiafico A, Ruozi B, Puglisi G, Furneri PM.

AAPS PharmSciTech. 2011 Jun;12(2):468-75. doi: 10.1208/s12249-011-9605-2. Epub 2011 Apr 9.

23.

Amphiphilic ion pairs of tobramycin with lipoamino acids.

Pignatello R, Mangiafico A, Basile L, Ruozi B, Furneri PM.

Eur J Med Chem. 2011 May;46(5):1665-71. doi: 10.1016/j.ejmech.2011.02.015. Epub 2011 Feb 19.

PMID:
21396748
24.

Management of aerobic vaginitis.

Tempera G, Furneri PM.

Gynecol Obstet Invest. 2010;70(4):244-9. doi: 10.1159/000314013. Epub 2010 Oct 16.

PMID:
21051843
25.

In vitro activity of cefditoren versus other antibiotics against S. pneumoniae clinical strains isolated in Italy.

Tempera G, Furneri PM, Ferranti C, Genovese C, Ripa S, Ungheri S, Nicoletti G.

Int J Immunopathol Pharmacol. 2010 Jul-Sep;23(3):833-40.

PMID:
20943054
26.

Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren.

Tempera G, Furneri PM, Carlone NA, Cocuzza C, Rigoli R, Musumeci R, Pilloni AP, Prenna M, Tufano MA, Tullio V, Vitali LA, Nicoletti G.

J Chemother. 2010 Jun;22(3):153-9.

27.

The impact of prulifloxacin on vaginal lactobacillus microflora: an in vivo study.

Tempera G, Furneri PM, Cianci A, Incognito T, Marano MR, Drago F.

J Chemother. 2009 Dec;21(6):646-50.

PMID:
20071288
28.

In vitro antiviral activity of Melaleuca alternifolia essential oil.

Garozzo A, Timpanaro R, Bisignano B, Furneri PM, Bisignano G, Castro A.

Lett Appl Microbiol. 2009 Dec;49(6):806-8. doi: 10.1111/j.1472-765X.2009.02740.x. Epub 2009 Sep 18.

29.

Synergism and postantibiotic effect of tobramycin and Melaleuca alternifolia (tea tree) oil against Staphylococcus aureus and Escherichia coli.

D'Arrigo M, Ginestra G, Mandalari G, Furneri PM, Bisignano G.

Phytomedicine. 2010 Apr;17(5):317-22. doi: 10.1016/j.phymed.2009.07.008. Epub 2009 Aug 20.

PMID:
19699074
30.

Econazole-polycarbophil, a new delivery system for topical therapy: microbiological and clinical results on vaginal candidiasis.

Furneri PM, Corsello S, Masellis G, Salvatori M, Cammarata E, Roccasalva LS, Mangiafico A, Tempera G.

J Chemother. 2008 Jun;20(3):336-40.

PMID:
18606589
31.

Topical kanamycin: an effective therapeutic option in aerobic vaginitis.

Tempera G, Abbadessa G, Bonfiglio G, Cammarata E, Cianci A, Corsello S, Raimondi A, Ettore G, Nicolosi D, Furneri PM.

J Chemother. 2006 Aug;18(4):409-14.

PMID:
17024797
32.

In vitro antimycoplasmal activity of Melaleuca alternifolia essential oil.

Furneri PM, Paolino D, Saija A, Marino A, Bisignano G.

J Antimicrob Chemother. 2006 Sep;58(3):706-7. Epub 2006 Jun 20. No abstract available.

PMID:
16787951
33.

Antimycoplasmal activity of hydroxytyrosol.

Furneri PM, Piperno A, Sajia A, Bisignano G.

Antimicrob Agents Chemother. 2004 Dec;48(12):4892-4.

34.

Effects on adhesiveness and hydrophobicity of sub-inhibitory concentrations of netilmicin.

Furneri PM, Garozzo A, Musumarra MP, Scuderi AC, Russo A, Bonfiglio G.

Int J Antimicrob Agents. 2003 Aug;22(2):164-7.

PMID:
12927958
35.

Combining molecular modeling with experimental methodologies: mechanism of membrane permeation and accumulation of ofloxacin.

Fresta M, Guccione S, Beccari AR, Furneri PM, Puglisi G.

Bioorg Med Chem. 2002 Dec;10(12):3871-89.

PMID:
12413839
36.

In vitro antimycoplasmal activity of oleuropein.

Furneri PM, Marino A, Saija A, Uccella N, Bisignano G.

Int J Antimicrob Agents. 2002 Oct;20(4):293-6.

PMID:
12385687
37.

Two new point mutations at A2062 associated with resistance to 16-membered macrolide antibiotics in mutant strains of Mycoplasma hominis.

Furneri PM, Rappazzo G, Musumarra MP, Di Pietro P, Catania LS, Roccasalva LS.

Antimicrob Agents Chemother. 2001 Oct;45(10):2958-60.

38.

Novel streptogramin antibiotics.

Bonfiglio G, Furneri PM.

Expert Opin Investig Drugs. 2001 Feb;10(2):185-98. Review.

PMID:
11178336
39.

Ofloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria.

Furneri PM, Fresta M, Puglisi G, Tempera G.

Antimicrob Agents Chemother. 2000 Sep;44(9):2458-64.

40.

Genetic basis of natural resistance to erythromycin in Mycoplasma hominis.

Furneri PM, Rappazzo G, Musumarra MP, Tempera G, Roccasalva LS.

J Antimicrob Chemother. 2000 Apr;45(4):547-8. No abstract available.

PMID:
10747837
41.

Correlation of trimethoprim and brodimoprim physicochemical and lipid membrane interaction properties with their accumulation in human neutrophils.

Fresta M, Furneri PM, Mezzasalma E, Nicolosi VM, Puglisi G.

Antimicrob Agents Chemother. 1996 Dec;40(12):2865-73.

42.

Levels of flurithromycin in female genital tissue.

Furneri PM, Cianci A, Campo L, Roccasalva LS, Tempera G, Fiore G, Palumbo G, Lepore AM, Nicoletti G.

Antimicrob Agents Chemother. 1995 Aug;39(8):1899-901.

43.

Pefloxacine mesilate- and ofloxacin-loaded polyethylcyanoacrylate nanoparticles: characterization of the colloidal drug carrier formulation.

Fresta M, Puglisi G, Giammona G, Cavallaro G, Micali N, Furneri PM.

J Pharm Sci. 1995 Jul;84(7):895-902.

PMID:
7562444
44.

Intracellular accumulation of ofloxacin-loaded liposomes in human synovial fibroblasts.

Fresta M, Spadaro A, Cerniglia G, Ropero IM, Puglisi G, Furneri PM.

Antimicrob Agents Chemother. 1995 Jun;39(6):1372-5.

45.

In-vitro antimycoplasmal activity of flurithromycin.

Furneri PM, Bisignano G, Cerniglia G, Tempera G, Nicoletti G.

J Antimicrob Chemother. 1995 Jan;35(1):161-5.

PMID:
7768764
46.

In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.

Furneri PM, Bisignano G, Cerniglia G, Nicoletti G, Cesana M, Tempera G.

Antimicrob Agents Chemother. 1994 Nov;38(11):2651-4.

47.

In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis.

Furneri PM, Bazzano M, Campo L, Cesana M, Tempera G.

Chemotherapy. 1994 Mar-Apr;40(2):104-8.

PMID:
8131632
48.

Laparoscopy diagnosis of chlamydial salpingitis using a tubal cytobrush.

Cianci A, Tempera G, Roccasalva L, Furneri PM, Nicoletti G, Palumbo G.

Fertil Steril. 1994 Jan;61(1):181-4.

PMID:
8293837
49.

Seroprevalence to some TORCH agents in a Sicilian female population of fertile age.

Condorelli F, Scalia G, Stivala A, Costanzo MC, Adragna AD, Franceschino C, Santagati MG, Furneri PM, Marino A, Castro A.

Eur J Epidemiol. 1993 May;9(3):341-3.

PMID:
8405322
50.

In vitro antiviral activity of four isothiazole derivatives against poliovirus type 1.

Pinizzotto MR, Garozzo A, Guerrera F, Castro A, La Rosa MG, Furneri PM, Geremia E.

Antiviral Res. 1992 Jul 1;19(1):29-41.

PMID:
1332598

Supplemental Content

Loading ...
Support Center